Keun Seok Lee

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Advanced Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer research : MCR

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Sun Young Rha, Pavani Chalasani, Wei Zhong, Diansong Zhou, Steven R Pirie-Shepherd, Abraham Cf Leung, Curigliano Giuseppe
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With HER2-Expressing Solid Tumors: A Phase 1 Dose Escalation Study. Molecular cancer therapeutics (2023)
Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi S El Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debasish Tripathy
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Eun Joo Yang, Keun Seok Lee, Myong Cheol Lim, Ji Yeon Baek, Ji-Youn Han, Eun-Seung Yu, Seung Hyun Chung
Symptom perception and functioning in patients with advanced cancer. PloS one 16 (2) (2021)
Yen-Shen Lu, Keun Seok Lee, Tsu-Yi Chao, Ling-Ming Tseng, Imjai Chitapanarux, Shin-Cheh Chen, Chien-Ting Liu, Joohyuk Sohn, Jee Hyun Kim, Yuan-Ching Chang, Youngsen Yang, Kanjana Shotelersuk, Kyung Hae Jung, Roberta Valenti, Cassandra Slader, Melissa Gao, Yeon Hee Park
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
In Hae Park, Han Na Yang, Su Yeon Jeon, Jung-Ah Hwang, Min Kyeong Kim, Sun-Young Kong, Sung Hoon Shim, Keun Seok Lee
Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer. Scientific reports 9 (1) (2019)
Jihyun Kim, Doyeong Yu, Youngmee Kwon, Keun Seok Lee, Sung Hoon Sim, Sun-Young Kong, Eun-Sook Lee, In Hae Park
Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response. Molecular cancer research : MCR 18 (2) (2019)